Sharing the Discovery of Multifunctional Anti Singlec15 mAb to Reverse Immune Suppression and Synergize with CIC Treatment

Time: 12:30 pm
day: Day One


• Outlining the Siglec15 target biology validation

• Discussing EPB-001 discovery with mRNADisTM technology

• Examining the in vitro and in vivo mechanism and efficacy studies of EPB-001

• Discussing next steps in the development plan